NMR logo

NMR

Nomura Holdings Inc ADR American Depositary Shares

$8.38
-$0.17(-1.99%)
67
Overall
100
Value
72
Tech
31
Quality
How is this score calculated?
Market Cap
$23.86B
Volume
2.00M
52W Range
$4.86 - $9.58
Target Price
$9.36

Company Overview

Mkt Cap$23.86BPrice$8.38
Volume2.00MChange-1.99%
P/E Ratio0.1Open$8.28
Revenue$1.7TPrev Close$8.55
Net Income$340.7B52W Range$4.86 - $9.58
Div Yield0.35%Target$9.36
Overall67Value100
Quality31Technical72

No chart data available

About Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers various financial products and investment consultation services. The Investment Management segment offers investment trust management, discretionary investment services, and investment funds. The Wholesale segment is involved in the sale, trading, agency execution, and market-making of fixed income and equity products, as well as structured financing and solutions. This segment also engages in underwriting various securities and other financial instruments, such as various classes of shares, convertible and exchangeable securities, investment grade and high yield debts, sovereign and emerging market debts, structured securities, and other securities; arranging private placements, as well as other capital raising activities; and provision of financial advisory services on business transactions comprising mergers and acquisitions, divestitures, spin-offs, capital structuring, corporate defense activities, leveraged buyouts, and risk solutions. The company was formerly known as The Nomura Securities Co., Ltd. and changed its name to Nomura Holdings, Inc. in October 2001. Nomura Holdings, Inc. was incorporated in 1925 and is headquartered in Tokyo, Japan.

Sector: Financial Services
Industry: Capital Markets

Latest News

H.C. Wainwright Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Neumora Therapeutics, Inc. today and set a price target of $18.00. Tsao covers the ...

TipRanks Auto-Generated Intelligence Newsdesk3 days ago

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

Christine Brown5 days ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Neumora Therapeutics, Inc. (NMRA) and Aurinia Pharmaceuticals (AUPH)

Christine Brown9 days ago

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA) and Weave Communications (WEAV)

Christine Brown10 days ago

RBC Capital Reaffirms Their Hold Rating on SNAM S.p.A. (0NQP)

TipRanks Auto-Generated Intelligence Newsdesk13 days ago
ABCD
1SymbolPriceChangeVol
2NMR$8.38-2.0%2.00M
3
4
5
6

Get Nomura Holdings Inc ADR American Depositary Shares Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.